In tested breast cancer tissues, we found that patients with high Plac1 expression are associated with worse clinical outcomes, which indicates that level of Plac1 expression in breast cancer tissues may serve as a risk predictor for patients. The gene discussed is PLAC1; the disease is breast cancer.